Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
about
Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenzaStructural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B VirusesInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceOseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferretsA mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal modelTreating and preventing influenza in aged care facilities: a cluster randomised controlled trialI222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) virusesEstimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza virusesThe N-terminal fragment of a PB2 subunit from the influenza A virus (A/Hong Kong/156/1997 H5N1) effectively inhibits RNP activity and viral replicationEpidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus NucleoproteinThe Emergence of Oseltamivir-Resistant Seasonal Influenza A (H1N1) Virus in Korea During the 2008-2009 Season.We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century.Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineagesDrug resistance in influenza A virus: the epidemiology and management.Tracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic.Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazil are endowed with permissive mutations, which compensate the loss of fitness imposed by antiviral resistance.Zanamivir-resistant influenza viruses with a novel neuraminidase mutationAnti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV)Optimizing tactics for use of the U.S. Antiviral Strategic National Stockpile for Pandemic (H1N1) Influenza, 2009.Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza VirusesIn vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCRAssessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.Drugs in development for influenza.Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus.The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo.Emergency surveillance of influenza during 2009 in the Chinese city of Qingdao.Influenza antivirals currently in late-phase clinical trial.Combination chemotherapy for influenza.Antiviral strategies for pandemic and seasonal influenzaPeramivir for the treatment of influenza.Decreased neuraminidase activity is important for the adaptation of H5N1 influenza virus to human airway epithelium.In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.Oseltamivir resistance in swine influenza: a brief discussion.Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.Influenza outbreaks in Singapore: epidemiology, diagnosis, treatment and prevention.
P2860
Q27437743-18A5F071-B649-436B-800B-1AA93F8EB325Q27663966-3172E517-1BDA-414B-B08E-30E548CC0605Q28282405-06ECB381-1CDF-4EB2-9378-9E21C0DC7EB2Q28474960-8B83F756-34FA-4ED9-9EF1-E8F08E577201Q28477927-A94AF5E2-799D-4D66-A0A3-0DD7A96844C6Q28484471-94501636-055A-4A92-8956-B12536849C2FQ28533778-C7F60406-3A7B-4CF4-8927-DC5F2F1142A0Q28541953-3B2096FD-1457-4F27-B573-97A9DC3A12C6Q28542440-BEE7ED94-0608-4260-8C66-93E34C640EF3Q28544035-F9D14FF1-3243-4FB6-B689-8C7B976A34EDQ28546866-94E2AA0C-AF84-4FB5-B853-57C2E166A060Q30224872-53A0577D-9334-4C9C-94E6-981720F67751Q30226747-39165DFE-DC49-478E-B53A-894DB0141C77Q30227284-26490A00-85B8-410B-88EB-A6FC8B4855E9Q30234600-2F896DF9-D648-4512-9FD9-B472DA067B1BQ30352557-59080CFF-6E70-478D-A51C-CD2302ECF5F4Q30372440-DD9D91E6-B446-4854-8D71-F6E20C8D9F7BQ30379353-AE5DE7F0-BA12-4A69-A7AF-39342AC0653AQ30382531-2A884436-B74D-44F7-A5C7-82C3F7DDACAFQ30383819-69A0A128-D19A-4300-8335-06C912BBD191Q30384081-E9D2F60F-0D78-49AF-95FB-CD8E4D866A81Q30387420-A17A407C-1B4E-4480-9D83-52EBB8C8F305Q30387832-D3ECBB48-119C-4390-9F2F-D58B0F20130CQ30387864-4D4544DB-6395-47E8-AEA1-FF8353F681F6Q30390818-8FC4A5FD-19B4-40A1-B77A-89E0D85AFC14Q30390856-717582B2-B947-4BCB-BEE9-9AC1D9306B85Q30391218-7FDFF600-2D65-470B-BAA4-A49A9D6DC8D0Q30391856-6F9F0163-BA75-4D34-A872-F688441EFBFDQ30391963-D27B2628-D69D-45D7-8BA7-633DC462F8A8Q30396361-EC5B5F3D-3A97-4868-8280-2E35A95133C0Q30397114-026C5A8E-309D-46F5-80A0-82C7FB021F46Q30398099-CD62D9F8-ED28-4809-A32E-6FCC6AA073B7Q30408112-101BC3C6-37A6-4818-B923-8FCD4687EDC2Q30408116-E88480B3-C3EC-4C12-A575-61134FC332F8Q30413154-B74DCA19-CCB5-4309-AAA5-8819EBDC392AQ30413673-E017025B-E060-4A2D-876F-9C7C4C240811Q30416440-7DD03499-0732-4255-B162-9BB35692BE69Q30417566-A1A27D2A-22EE-4910-8E5D-FAE3683E7D94Q30419391-C64EB14D-8CE9-4020-9489-6A49B34C3696Q30420892-CBE03B44-5A36-4F6F-85A6-09F2303CA178
P2860
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Emergence and spread of oselta ...... th East Asia and South Africa.
@en
Emergence and spread of oselta ...... th East Asia and South Africa.
@nl
type
label
Emergence and spread of oselta ...... th East Asia and South Africa.
@en
Emergence and spread of oselta ...... th East Asia and South Africa.
@nl
prefLabel
Emergence and spread of oselta ...... th East Asia and South Africa.
@en
Emergence and spread of oselta ...... th East Asia and South Africa.
@nl
P2093
P50
P1433
P1476
Emergence and spread of oselta ...... th East Asia and South Africa.
@en
P2093
Apandi Mohd
Aurélie Guigon
Bruce Harrower
Chris Birch
David Smith
Dominic Dwyer
Holly D'Souza
Ip Peng Kei
Joanne Ernest
P356
10.1016/J.ANTIVIRAL.2009.03.003
P577
2009-03-24T00:00:00Z